1. Home
  2. QNCX vs CTMX Comparison

QNCX vs CTMX Comparison

Compare QNCX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • CTMX
  • Stock Information
  • Founded
  • QNCX 2012
  • CTMX 2008
  • Country
  • QNCX United States
  • CTMX United States
  • Employees
  • QNCX N/A
  • CTMX N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNCX Health Care
  • CTMX Health Care
  • Exchange
  • QNCX Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • QNCX 70.4M
  • CTMX 85.3M
  • IPO Year
  • QNCX 2019
  • CTMX 2015
  • Fundamental
  • Price
  • QNCX $1.60
  • CTMX $0.84
  • Analyst Decision
  • QNCX Strong Buy
  • CTMX Buy
  • Analyst Count
  • QNCX 4
  • CTMX 6
  • Target Price
  • QNCX $9.50
  • CTMX $5.77
  • AVG Volume (30 Days)
  • QNCX 130.8K
  • CTMX 943.6K
  • Earning Date
  • QNCX 11-13-2024
  • CTMX 03-10-2025
  • Dividend Yield
  • QNCX N/A
  • CTMX N/A
  • EPS Growth
  • QNCX N/A
  • CTMX N/A
  • EPS
  • QNCX N/A
  • CTMX 0.16
  • Revenue
  • QNCX N/A
  • CTMX $126,617,000.00
  • Revenue This Year
  • QNCX N/A
  • CTMX $22.55
  • Revenue Next Year
  • QNCX N/A
  • CTMX N/A
  • P/E Ratio
  • QNCX N/A
  • CTMX $5.39
  • Revenue Growth
  • QNCX N/A
  • CTMX 33.66
  • 52 Week Low
  • QNCX $0.51
  • CTMX $0.79
  • 52 Week High
  • QNCX $2.45
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 43.92
  • CTMX 45.15
  • Support Level
  • QNCX $1.49
  • CTMX $0.82
  • Resistance Level
  • QNCX $1.69
  • CTMX $0.98
  • Average True Range (ATR)
  • QNCX 0.14
  • CTMX 0.06
  • MACD
  • QNCX 0.00
  • CTMX 0.01
  • Stochastic Oscillator
  • QNCX 46.15
  • CTMX 33.58

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: